Medtech
Medtech breakthroughs happen with Cooley
Coordinated legal counsel for medtech and medical device innovators navigating regulation, capital, IP, commercialization, growth, and bet-the-company disputes and investigations
Why Cooley
-
Legal partner to medtech innovators and investors
Cooley advises innovative medtech and medical device companies operating in an environment where regulatory decisions directly shape product design, commercial opportunity, capital strategy and long-term value. Whether the device is an algorithm or an implant, we meet our clients with the technical and legal insight needed to accelerate their business.
-
Full-service counsel – for every stage
From early financing and FDA approval to global scale and exit, our cohesive approach helps venture-backed and global medtech and medical device companies seize opportunities, manage risk and grow. Our unrivalled experience and industry relationships drive strategic solutions across regulatory, reimbursement, corporate, IP, and complex dispute and investigation matters.
-
Commercial advice, real-world judgment
Our teams include former regulatory agency attorneys, industry professionals, technically trained lawyers and trial-tested litigators. We deliver actionable, business-centered judgment to meet fast product cycles and thorny regulatory and reimbursement issues, in addition to shaping IP strategy and managing complex litigation, investigations, and global expansion.
-
US medtech regulatory fluency supporting global ambition
From the US, Europe and Asia, we advise medtech companies and investors worldwide on accessing and scaling in the US market – the most critical regulatory and commercial gateway.
-
Market-leading deal volume in the medtech industry
Cooley consistently leads in medtech venture financings, IPOs and M&A, advising on hundreds of deals annually and helping our clients raise billions in capital.
-
Strategic medtech IP protection and litigation
With Cooley, innovators have coordinated IP strategy as they scale – across prosecution, counseling and litigation.
-
High-stakes litigation and investigations
When disputes or enforcement risk threaten momentum or value, Cooley moves quickly. Our litigators and investigations team handle bet-the-company matters for medtech and medical device companies – from competitor disputes and product suits to government and internal investigations, including healthcare and FDA compliance.
By the numbers
-
300+
medtech companies represented around the world
-
1,000+
IP due diligence reviews in life sciences and medical device deals/transactions
-
40%
of medtech/digital health IPOs since 2019 involved Cooley counsel
-
40+
years of regulatory experience in FDA’s Office of the Chief Counsel
-
425+
litigators in major business and technology centers worldwide, handling high-stakes litigations for cutting-edge companies
Regulatory insight you can use: AI and medical devices
Explore Cooley’s practical guidance on FDA regulation of AI and machine learning in medical devices.
recognition
- Chambers USA: Healthcare: Medical Products Regulatory Life Sciences (2025)
- Chambers USA: Intellectual Property – Nationwide (2025)
- Law360: Life Sciences Practice Group of the Year (2022 – 2025)
- LMG Life Sciences Americas: Corporate Firm of the Year (2023 – 2025)
- LMG Life Sciences: FDA Litigation & Enforcement Firm of the Year, shortlist (2025)
- LMG Life Sciences: General Patent Litigation Firm of the Year, finalist (2024)
- The American Lawyer: IP Litigation Department of the Year, finalist (2023, 2025)
- The American Lawyer’s Litigation Daily Litigator of the Week: 60+ mentions since 2022
- Life Sciences IP Review: Shortlist honors for Life Sciences Patent Network Awards (2026)
-
As a leading life sciences firm, how does Cooley support medtech companies?
Cooley supports medtech innovators across the spectrum – from software-enabled devices and AI to implantable and combination products. We bring together market-leading life sciences, healthcare and digital health capabilities with a medtech team built for regulated devices, where FDA and healthcare strategy shapes product design, financing timelines and exit paths. The result is coordinated counsel across corporate, regulatory, IP and disputes – aligned to how devices are built, approved and scaled.
-
Do you work with early-stage medtech companies?
Cooley works with emerging and venture-backed medtech companies and supports them through financings, strategic partnering, regulatory milestones and exit. Our team delivers coordinated legal support, including medical device IP and patent strategy, FDA and healthcare regulatory advice, and an unrivalled corporate platform to help startups commercialize their innovations and scale to meet their ambition.
-
What’s your role in medtech financings, M&A and strategic transactions?
We advise companies and investors on venture financings, growth equity, IPO readiness, M&A and commercial collaborations across the medtech life cycle. We also bring device-focused diligence that connects regulatory posture, quality systems, IP and product risk to deal terms and post-close integration.
-
Can Cooley help with IP strategy and protect freedom to operate?
We align patent, trade secret and commercial strategy with product roadmaps and regulatory milestones, and we support IP diligence for financings and M&A. When issues escalate, we handle IP and competitor disputes with trial-ready teams that understand the technology and the business objectives.
-
How does Cooley counsel medtech companies in litigation and investigations?
We help medtech companies manage disputes and scrutiny without losing focus on development and commercialization. Our team pairs trial experience with device and healthcare regulatory context to shape strategy early, coordinates with in-house and technical stakeholders, and guides matters through resolution – including competitor and contract disputes, product and advertising challenges, and government and internal investigations.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.